159 related articles for article (PubMed ID: 38406883)
1. Management of malignant ureteric obstruction with ureteric stenting or percutaneous nephrostomy.
Blackmur J;
Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38406883
[TBL] [Abstract][Full Text] [Related]
2. [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents].
Netsch C; Becker B; Gross AJ
Urologe A; 2016 Nov; 55(11):1497-1510. PubMed ID: 27787581
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous urinary drainage and ureteric stenting in malignant disease.
Allen DJ; Longhorn SE; Philp T; Smith RD; Choong S
Clin Oncol (R Coll Radiol); 2010 Nov; 22(9):733-9. PubMed ID: 20728326
[TBL] [Abstract][Full Text] [Related]
4. Malignant ureteral obstruction: comparison of metallic, 8 French and 6 French ureteric stents after failure of initial ureteric stent.
Ong K; Chen J; Kong J; Kuan M
World J Urol; 2024 Feb; 42(1):92. PubMed ID: 38386090
[TBL] [Abstract][Full Text] [Related]
5. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
[TBL] [Abstract][Full Text] [Related]
6. The role of percutaneous nephrostomy in malignant ureteric obstruction.
Wilson JR; Urwin GH; Stower MJ
Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous nephrostomy versus indwelling ureteral stents in patients with bilateral nongenitourinary malignant extrinsic obstruction.
Park DS; Park JH; Lee YT
J Endourol; 2002 Apr; 16(3):153-4. PubMed ID: 12028623
[TBL] [Abstract][Full Text] [Related]
8. Use of percutaneous nephrostomy in malignant ureteric obstruction.
Chapman ME; Reid JH
Br J Radiol; 1991 Apr; 64(760):318-20. PubMed ID: 2025771
[TBL] [Abstract][Full Text] [Related]
9. Tandem Ureteral Stents for Malignant Ureteral Obstruction.
Haifler M; Shvero A; Zilberman D; Ramon J; Winkler H; Margel D; Kleinmann N
J Endourol; 2020 Feb; 34(2):222-226. PubMed ID: 31724450
[No Abstract] [Full Text] [Related]
10. Percutaneous nephrostomy in obstructing pelvic malignancy does not facilitate further oncological treatment.
Folkard SS; Banerjee S; Menzies-Wilson R; Reason J; Psallidas E; Clissold E; Al-Mushatat A; Chaudhri S; Green JSA
Int Urol Nephrol; 2020 Sep; 52(9):1625-1628. PubMed ID: 32319003
[TBL] [Abstract][Full Text] [Related]
11. The management of ureteric obstruction secondary to malignant pelvic disease.
Chitale SV; Scott-Barrett S; Ho ET; Burgess NA
Clin Radiol; 2002 Dec; 57(12):1118-21. PubMed ID: 12475538
[TBL] [Abstract][Full Text] [Related]
12. Ureteric complications of renal transplantation.
Kashi SH; Lodge JP; Giles GR; Irving HC
Br J Urol; 1992 Aug; 70(2):139-43. PubMed ID: 1393435
[TBL] [Abstract][Full Text] [Related]
13. Risk factors in the prediction of long-term patency of Resonance metallic ureteric stent in malignant ureteric obstruction.
Ho BSH; Chiu PKF; Lam W; Wong JHF; Wong CKW; Lai TCT; Tsang CF; Ng ATL; Chan CK; Ma WK; Ng CF; Tsu JHL
BJUI Compass; 2020 May; 1(2):74-81. PubMed ID: 35474710
[TBL] [Abstract][Full Text] [Related]
14. The use of percutaneous nephrostomy in patients with ureteric obstruction undergoing renal transplantation.
Ehrlichman RJ; Bettman M; Kirkman RL; Tilney NL
Surg Gynecol Obstet; 1986 Feb; 162(2):121-5. PubMed ID: 3511554
[TBL] [Abstract][Full Text] [Related]
15. Factors Associated with Ureteral Stent Failure in Patients with Malignant Ureteral Obstruction.
Pickersgill NA; Wahba BM; Vetter JM; Cope SJ; Barashi NS; Henning GM; Du K; Figenshau RS; Desai AC; Venkatesh R
J Endourol; 2022 Jun; 36(6):814-818. PubMed ID: 35018790
[No Abstract] [Full Text] [Related]
16. Ureteric stricture formation following ureteric instrumentation in patients with a nephrostomy drain in place.
O'Sullivan DC; Lemberger RJ; Bishop MC; Bates CP; Dunn M
Br J Urol; 1994 Aug; 74(2):165-9. PubMed ID: 7921932
[TBL] [Abstract][Full Text] [Related]
17. [Endoluminal therapy for bilateral malignant ureteric obstruction].
Liu YD; Yuan J; Huang ST; Luo JT; Zeng GH; Xun L
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):717-9. PubMed ID: 18246808
[TBL] [Abstract][Full Text] [Related]
18. Quality of life with tandem ureteral stents compared to percutaneous nephrostomy for malignant ureteral obstruction.
Shvero A; Haifler M; Mahmud H; Dotan Z; Winkler H; Kleinmann N
Support Care Cancer; 2022 Nov; 30(11):9541-9548. PubMed ID: 36056940
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes After Urinary Diversion for Malignant Ureteral Obstruction Secondary to Non-urologic Cancer: An Analysis of 778 Cases.
Heo JE; Jeon DY; Lee J; Ham WS; Choi YD; Jang WS
Ann Surg Oncol; 2021 Apr; 28(4):2367-2373. PubMed ID: 33389298
[TBL] [Abstract][Full Text] [Related]
20. Ureteric stents vs percutaneous nephrostomy for initial urinary drainage in children with obstructive anuria and acute renal failure due to ureteric calculi: a prospective, randomised study.
ElSheemy MS; Shouman AM; Shoukry AI; ElShenoufy A; Aboulela W; Daw K; Hussein AA; Morsi HA; Badawy H
BJU Int; 2015 Mar; 115(3):473-9. PubMed ID: 24698195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
